Posted by shellson2 on 13th of Feb 2025 at 04:53 pm
TIL--InStil Bio. A company I've been holding for a little while
now--had a good day today on positive trial news, up 24%. What I
find most interesting is the analyst PT's
(The Baird is now 5 months old, but hefty
nonetheless).
Posted by shellson2 on 13th of Feb 2025 at 02:59 pm
WGS--GeneDx
GeneDx Announces ultraRapid Whole Genome
Sequencing, Delivering Actionable Results in as soon as 48 Hours to
Inform Care for Critically Ill NICU and PICU Patients
Posted by shellson2 on 12th of Feb 2025 at 11:03 am
SENS--EU compliance may be next trigger for
stock
Eversense 365 is the world's first and only one
year CGM, which was approved by the United States (US) Food and
Drug Administration in September of 2024 and launched across the
country in October of the same year.
The Eversense 365 CE Mark submission was prepared
in compliance with the EU Medical Device Regulation (MDR) and,
upon approval, would enable the commercialization of Eversense 365
in European Union (EU) member countries by Senseonics' commercial
partner, Ascensia Diabetes Care. Following CE Mark approval
in Europe, the Company plans to distribute the Eversense 365
System in Germany, Italy, Spain (including Andorra), Poland,
Switzerland and Sweden.
"Completing the CE Mark submission for Eversense
365 brings us a step closer to improving lives and health outcomes
for patients in Europe. Given the success we have had to date with
the US launch of Eversense 365 by our partner, Ascensia, we look
forward to the opportunity to offer a ‘once a year' solution for
glucose control to the millions of people living with diabetes in
the European Union," said Tim Goodnow, PhD, President and Chief
Executive Officer of Senseonics.
The community is delayed by three days for non registered users.
TIL--InStil Bio. A company I've
Posted by shellson2 on 13th of Feb 2025 at 04:53 pm
TIL--InStil Bio. A company I've been holding for a little while now--had a good day today on positive trial news, up 24%. What I find most interesting is the analyst PT's
(The Baird is now 5 months old, but hefty nonetheless).
The stock was once in $80's last Fall.
Baird
Reiterates
Outperform
$180
16/09/2024 ET
Jefferies
Upgrades
Buy
$52
07/01/2025 ET
HC Wainwright & Co.
Reiterates
Buy
$110
18/11/2024 ET
WGS--GeneDx GeneDx Announces ultraRapid Whole Genome Sequencing,
Posted by shellson2 on 13th of Feb 2025 at 02:59 pm
WGS--GeneDx
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
I'm short IONQ now.
LMND hit yesterday after forming bear flag and remains vulnerable ...
Posted by shellson2 on 13th of Feb 2025 at 01:10 pm
I'm short IONQ now.
Senseonics Holdings, Inc. Schedules Fourth
I try to follow as much biotech as possible...this is ...
Posted by shellson2 on 13th of Feb 2025 at 11:56 am
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for March 3, 2025 at 4:30 P.M. Eastern Time
TEM--Tempest, new 52 week-r
Posted by shellson2 on 13th of Feb 2025 at 10:38 am
TEM--Tempest, new 52 week-r
HIMS--big pop up (lol). 10+%
Posted by shellson2 on 13th of Feb 2025 at 09:49 am
HIMS--big pop up (lol). 10+%
Up 15%, way above volume
I try to follow as much biotech as possible...this is ...
Posted by shellson2 on 13th of Feb 2025 at 09:44 am
Up 15%, way above volume
SENS--EU compliance may be next
I try to follow as much biotech as possible...this is ...
Posted by shellson2 on 12th of Feb 2025 at 11:03 am
SENS--EU compliance may be next trigger for stock
Eversense 365 is the world's first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of the same year.
The Eversense 365 CE Mark submission was prepared in compliance with the EU Medical Device Regulation (MDR) and, upon approval, would enable the commercialization of Eversense 365 in European Union (EU) member countries by Senseonics' commercial partner, Ascensia Diabetes Care. Following CE Mark approval in Europe, the Company plans to distribute the Eversense 365 System in Germany, Italy, Spain (including Andorra), Poland, Switzerland and Sweden.
"Completing the CE Mark submission for Eversense 365 brings us a step closer to improving lives and health outcomes for patients in Europe. Given the success we have had to date with the US launch of Eversense 365 by our partner, Ascensia, we look forward to the opportunity to offer a ‘once a year' solution for glucose control to the millions of people living with diabetes in the European Union," said Tim Goodnow, PhD, President and Chief Executive Officer of Senseonics.
SENS-- New 52wk today, vol is
I try to follow as much biotech as possible...this is ...
Posted by shellson2 on 12th of Feb 2025 at 10:58 am
SENS--
New 52wk today, vol is above average. Their next business update could be very meaningful. Will dig for that info.
EH—new hi’s, up 18%. Could
EH--has been mentioned on the boards a few times (by ...
Posted by shellson2 on 12th of Feb 2025 at 10:20 am
EH—new hi’s, up 18%. Could just be getting started.
HSAI--picked this up recently, has
Posted by shellson2 on 12th of Feb 2025 at 09:14 am
HSAI--picked this up recently, has hit new hi's. China LiDAR space.
UPST--Didnt play it...up 15%
SMCI reporting today. Could be exciting. Also CFLT.
Posted by shellson2 on 11th of Feb 2025 at 04:21 pm
UPST--Didnt play it...up 15%
SMCi see-sawing
LYFT DASH Z lower after reporting and GILD higher
Posted by shellson2 on 11th of Feb 2025 at 04:18 pm
SMCi see-sawing
UPST too. Wild one
SMCI reporting today. Could be exciting. Also CFLT.
Posted by shellson2 on 11th of Feb 2025 at 03:32 pm
UPST too. Wild one
The Meta streak is one
Posted by shellson2 on 11th of Feb 2025 at 03:27 pm
The Meta streak is one for the ages...todays move is on half volume. Maybe inflation data will have them getting on the elevator this week
NOTE--another leg up. Over 2.15
Posted by shellson2 on 11th of Feb 2025 at 01:38 pm
NOTE--another leg up. Over 2.15 its gets very interesting
ATAT--large Chinese hotel operator. Should
Posted by shellson2 on 11th of Feb 2025 at 12:46 pm
ATAT--large Chinese hotel operator. Should move with the up trending market over there.
Bonds up less than I
Posted by shellson2 on 11th of Feb 2025 at 12:41 pm
Bonds up less than I expected so far...
picked up some down at
TEM - tagged supply zone and gave up most of ...
Posted by shellson2 on 11th of Feb 2025 at 12:39 pm
picked up some down at $70
If this is correct, then
AIFF--now may be a good time to look at. Popped ...
Posted by shellson2 on 11th of Feb 2025 at 11:45 am
If this is correct, then they have 4 months of cash on hand. Credit--BioPharm Catalyst
cash on hand--6.6mm
Offering will come soon I bet
biopharmcatalyst.com
Just a moment...